|
|
Volumn 12, Issue 3, 2011, Pages 163-164
|
|
Rituximab in the treatment of MuSK antibody-positive myasthenia gravis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
ENZYME ANTIBODY;
IMMUNOGLOBULIN;
MUSCLE SPECIFIC KINASE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
PYRIDOSTIGMINE;
RITUXIMAB;
UNCLASSIFIED DRUG;
ADULT;
ARM WEAKNESS;
CASE REPORT;
DIPLOPIA;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG MEGADOSE;
DRUG SUBSTITUTION;
DYSARTHRIA;
DYSPHAGIA;
DYSPNEA;
FEMALE;
HUMAN;
IMMUNOASSAY;
LETTER;
MYASTHENIA GRAVIS;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PTOSIS;
TREATMENT RESPONSE;
ADULT;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
AUTOANTIBODIES;
AUTOANTIGENS;
FEMALE;
HUMANS;
IMMUNOLOGIC FACTORS;
MIDDLE AGED;
MYASTHENIA GRAVIS;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTORS, CHOLINERGIC;
|
|
EID: 79952120618
PISSN: 15220443
EISSN: 15371611
Source Type: Journal
DOI: 10.1097/CND.0b013e3181df2b3e Document Type: Letter |
|
Times cited : (19)
|
|
References (5)
|
